Free Trial

Green Thumb Industries (OTC:GTBIF) Shares Down 3.2% - Should You Sell?

Green Thumb Industries logo with Medical background

Shares of Green Thumb Industries Inc. (OTC:GTBIF - Get Free Report) fell 3.2% during mid-day trading on Thursday . The company traded as low as $5.70 and last traded at $5.83. 385,731 shares changed hands during mid-day trading, a decline of 17% from the average session volume of 466,996 shares. The stock had previously closed at $6.02.

Green Thumb Industries Stock Performance

The business has a fifty day moving average of $5.77 and a two-hundred day moving average of $7.26. The firm has a market capitalization of $1.17 billion, a price-to-earnings ratio of 20.50 and a beta of 1.32.

About Green Thumb Industries

(Get Free Report)

Green Thumb Industries Inc manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States. It operates through two segments, Retail and Consumer Packaged Goods. The company offers cannabis flower; processed and packaged products, including pre-rolls, concentrates, vapes, capsules, tinctures, edibles, topicals, and other cannabis-related products under the &Shine, Beboe, Dogwalkers, Doctor Solomon's, Good Green, incredibles, and RHYTHM brands.

Recommended Stories

Should You Invest $1,000 in Green Thumb Industries Right Now?

Before you consider Green Thumb Industries, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Green Thumb Industries wasn't on the list.

While Green Thumb Industries currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Dirt-Cheap Stocks in a Market That’s Getting Expensive
Top 3 Defense Stocks to Profit From $175 Billion Golden Dome
Top 5 Stocks for June: AI Picks That Aren’t NVIDIA

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines